Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prophylaxis for infective endocarditis. Who needs it? How effective is it?

N Press1, V Montessori

  • 1University of British Columbia, Vancouver.

Canadian Family Physician Medecin De Famille Canadien
|January 6, 2001
PubMed
Summary

Antibiotic prophylaxis is crucial for preventing infective endocarditis in high-risk patients with cardiac disease. A single oral dose of amoxicillin before procedures causing bacteremia is recommended to prevent this serious condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Debating clinical utility.

Public health genomics·2010
Same author

Erysipelothrix rhusiopathiae endocarditis and presumed osteomyelitis.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2007
Same author

Pentafuside (Trimeris).

IDrugs : the investigational drugs journal·2005
Same author

Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort.

AIDS care·2005
Same author

Respiratory failure associated with the lipodystrophy syndrome in an HIV-positive patient with compromised lung function.

Canadian respiratory journal·2001
Same author

Clinical and microbiological follow-up of an outbreak of Yersinia pseudotuberculosis serotype Ib.

Scandinavian journal of infectious diseases·2001

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Infective endocarditis (IE) remains a significant cause of morbidity and mortality.
  • Preventive strategies, including antibiotic prophylaxis, are vital for high-risk individuals.

Purpose of the Study:

  • To review current guidelines for antibiotic prophylaxis in IE prevention.
  • To highlight recent updates and ongoing debates surrounding these recommendations.

Main Methods:

  • Analysis of physiologic and in vitro studies.
  • Review of animal models and retrospective human case analyses.
  • Examination of systematic reviews and existing clinical guidelines; recommendations based on consensus due to lack of randomized trials.

Main Results:

Related Experiment Videos

  • Antibiotic prophylaxis is indicated for high- and moderate-risk patients with cardiac conditions.
  • Prophylaxis should be administered prior to procedures with a high likelihood of bacteremia from endocarditis-causing organisms like viridans streptococci.
  • A single oral dose of 2g amoxicillin, taken 1 hour before the procedure, is generally sufficient.

Conclusions:

  • Antibiotic prophylaxis is an important measure against preventable infective endocarditis.
  • The cost-benefit analysis supports prophylaxis for high- and moderate-risk cardiac patients.
  • Continued vigilance and adherence to guidelines are essential for reducing IE complications.